UBS sees more downside and than upside in Biogen stock
Go back to UBS sees more downside and than upside in Biogen stock| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 225.71 +7.28 (3.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $218.43 | 52 Week High | $333.65 | |||
| Open | $220.62 | 52 Week Low | $223.02 | |||
| Day High | $227.20 | P/E | 28.90 | |||
| Day Low | $219.23 | EPS | $7.81 | |||
| Volume | 815,009 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1179.27 +9.67 (0.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1169.60 | 52 Week High | $88.16 | |||
| Open | $1153.56 | 52 Week Low | $67.88 | |||
| Day High | $1179.82 | P/E | 272.98 | |||
| Day Low | $1151.67 | EPS | $4.32 | |||
| Volume | 1,392,799 | |||||



